Publications
Newsletter
Press Releases
Booklets
Articles
MBC
EBCC
TBCT
Newsletter
Newsletter
- ED Newsletter 2022
- ED Newsletter 2021
- ED Newsletter 2020
- ED Newsletter 2019
- ED Newsletter 2018
- ED Newsletter 2017
- ED Newsletter 2016
- ED Newsletter 2015
- ED Newsletter 2014
- ED Newsletter 2013
E-Newsletter
2022
2021
2020
2019
2018
Press Releases
- ED Event at the Parliament 28.02.2023 – press release
- EBCC13 Press release 21 November 2022
- Breast Health Day 15 October 2022
- ED MBC Advocacy Webinar 17-18 June 2022
- 15th Pan European Virtual Conference Press Release 26 October 2021
- Breast Health Day 15 October 2021
- ED MBC Advocacy Webinar 18-19 June 2021
- ED President Tanja Spanic spoke at the BECA hearing on “Why cancer screening and early detection matter” 18 March 2021
- ED CEO Susan Knox to retire, Marzia Zambon appointed new Executive Director January 2021
- ED MBC Advocacy Webinar 30-31 October 2020
- EBCC-12 Press Release October 2020
- ED attends the launch of Europe’s Beating Cancer Plan: Let’s strive for more on World Cancer Day 4 February 2020
- ED’s former President Stella Kyriakides confirmed as the new European Commissioner for Health Press Release 27 November 2019
- 14th Pan European Conference Press Release 30 October 2019
- Transforming Breast Cancer Together meeting at the European Parliament 16 October 2019
- 2nd MBC Advocacy Conference 7-8 June 2019
- 1st MBC Advocacy Training Course 28-30 Sept. 2018
- EBCC-11 Press Release March 2018
Booklets
Genomics, Genetics and Personalised Medicine
Clinical Trials
- Clinical Trials Booklet 2019
- Exploring the Role of Advocates in Breast Cancer Research
- Advocate’s Guide to Understanding Breast Cancer Research
EU Guidelines
- ECIBC- European Commission initiative on Breast Cancer booklet 2022
- ED Advocates Guide to the ECIBC European Commission Initiative on Breast Cancer
- ED Short Guide to the EU Guidelines
- Metastatic Breast Cancer Annex to the Short Guides
Europa Donna Surveys
- ED Survey on COVID-19 and the State of Breast Services in Europe 2022
- ED 2021 MBC Survey Report
- ED Breast Cancer Survey Report 2020
- Addressing the Challenges of Breast Cancer Care During the COVID-19 Pandemic in Europe
General Brochure
Articles
Europa Donna Articles
- Womens Health Campaign- article by Barbara Klein September 2021– “Why living a healthy lifestyle is important for your breast health”
- The Breast – article by Susan Knox June 2015 – The European Patient Advocacy Perspective on Specialist Breast Units
- The Breast – article by Susan Knox Feb 2011–The European advocacy perspective on mammography screening
- The Breast – article by Susan Knox March 2009 – Health economic decision making in Europe – a new priority for breast cancer advocacy
- Cancerworld article about Breast Health Day – Helping Women Make the Right Choices – Europa Donna launches Breast Health Day
- CancerWorld interview with Stella Kyriakides – Stella Kyriakides the torch bearer
- BIG newsletter – article by Deirdre O’Connell – EUROPA DONNA – The European Breast Cancer Coalition
Articles in Collaboration with Others
- Should Acellular Dermal Matrices Be Used for Implant-based Breast Reconstruction after Mastectomy? Clinical Recommendation Based on the GRADE Approach
- Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer-Oct 2022 Ann Ancol.
- Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification-2022 Ann Oncol.
- ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer Published in 2021 – Ann Oncol. 2021(32): Authors: A. Gennari, F. André, C. H. Barrios, et al, on behalf of the ESMO Guidelines Committee
- Cancer Discovery 28 June 2021: Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative
- The Lancet Oncology May 2021– Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)
- The Lancet Oncology March 2021– 70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age
- The Lancet Oncology January 2021 – Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
- Health and Quality of Life Outcomes 2020– Development and use of health outcome descriptors: a guideline development case study
- European Journal of Surgical Oncology 2020–Breast cancer treatment in the modern era of multidisciplinary oncology: Now we need new models of training
- Development and use of health outcome descriptors: a guideline development case study-2020
- European Journal of Surgical Oncology April 2020 –Theoretical and practical knowledge curriculum for European Breast Surgeons
- SIOG Task Force paper on Quality of Life (QoL) in older oncology patients 2018 – “Addressing the quality of life needs of older patients with cancer: A SIOG consensus paper and practical guide”
- The New England Journal of Medicine August 2016 – 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- The International Consortium for Health Outcomes Measurement (ICHOM) Initiative 2016 – “A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer”
- Policy Statement on Multidisciplinary Cancer Care 2014
MBC
MBC
- Highlights from ED’s MBC Advocacy Webinar June 2022
- ED 2021 MBC Survey Report
- Highlights from ED’s MBC Advocacy Webinar June 2021
- Highlights from ED’s MBC Advocacy Webinar Oct 2020
- Highlights from ED’s MBC Advocacy Conference 2019
- Highlights from ED’s MBC Advocacy Training Course 2018
- 1st ED MBC Conference Summary 2017
- Metastatic Breast Cancer: Focus for Advocacy 2014
- Perspectives on Advocacy for Women with Metastatic Breast Cancer 2012
- Metastatic Breast Cancer Annex to the Short Guides
EBCC
EBCC
- European Breast Cancer Conference – EBCC 13 Manifesto: Balancing pros and cons for contralateral prophylactic mastectomy. 2022
- European Breast Cancer Conference- EBCC 12 Manifesto: Why is appropriate healthcare inaccessible for many European breast cancer patients? 2020
- European Breast Cancer Conference -EBCC 11 – Manifesto: Genetic risk prediction testing in breast cancer 2018
- European Breast Cancer Conference -EBCC 10- Manifesto on breast centres/units 2016
- European Breast Cancer Conference -EBCC 9-Manifesto on Optimal Pathology 2014
- European Breast Cancer Conference -EBCC 6- Take Home Messages 2008
- European Breast Cancer Conference -EBCC 5- Manifesto 2006
- European Breast Cancer Conference -EBCC 4- Hamburg Statement 2004
- European Breast Cancer Conference -EBCC 3- Barcelona Statement 2002
- European Breast Cancer Conference -EBCC 2- Brussels Statement 2000
- European Breast Cancer Conference -EBCC 1- Florence Statement 1998
TBCT
TBCT
- Transforming Breast Cancer Together 12 October 2022: Better breast cancer care for a better life: A call to action
- Transforming Breast Cancer Together 2 July 2021: Statement in response to the European Parliament Special Committee’s on Beating Cancer draft report
- Transforming Breast Cancer Together June 2021: Renewed Call for Change
- Transforming Breast Cancer Together: Impact of COVID-19 on Breast Cancer Patients-April 2020
- The Breast – article August 2019 – Transforming Breast Cancer Together: European elections manifesto 2019 seizing the opportunities for breast cancer patients
- Transforming Breast Cancer Together: Elections Manifesto 2019
- Transforming Breast Cancer Together: White Paper 2019
- Transforming Breast Cancer Together: Call for Change 2018
